LeMaitre Vascular Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $63.38
- Today's High:
- $65.35
- Open Price:
- $64.25
- 52W Low:
- $40.4063
- 52W High:
- $67.9118
- Prev. Close:
- $64.02
- Volume:
- 132400
Company Statistics
- Market Cap.:
- $1.44 billion
- Book Value:
- 12.382
- Revenue TTM:
- $169.16 million
- Operating Margin TTM:
- 17.84%
- Gross Profit TTM:
- $104.90 million
- Profit Margin:
- 12.2%
- Return on Assets TTM:
- 6.21%
- Return on Equity TTM:
- 7.76%
Company Profile
LeMaitre Vascular Inc had its IPO on 2006-10-19 under the ticker symbol LMAT.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. LeMaitre Vascular Inc has a staff strength of 591 employees.
Stock update
Shares of LeMaitre Vascular Inc opened at $64.25 at the start of the last trading session i.e. 2023-06-03.
The stocks traded within a range of $63.38 - $65.35, and closed at $64.91.
This is a +1.39% increase from the previous day's closing price.
A total volume of 132,400 shares were traded at the close of the day’s session.
In the last one week, shares of LeMaitre Vascular Inc have increased by +7.99%.
LeMaitre Vascular Inc's Key Ratios
LeMaitre Vascular Inc has a market cap of $1.44 billion, indicating a price to book ratio of 4.0406 and a price to sales ratio of 6.2693.
In the last 12-months LeMaitre Vascular Inc’s revenue was $169.16 million with a gross profit of $104.90 million and an EBITDA of $39.60 million. The EBITDA ratio measures LeMaitre Vascular Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, LeMaitre Vascular Inc’s operating margin was 17.84% while its return on assets stood at 6.21% with a return of equity of 7.76%.
In Q1, LeMaitre Vascular Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 19%.
LeMaitre Vascular Inc’s PE and PEG Ratio
- Forward PE
- 40.3226
- Trailing PE
- 69.7957
- PEG
- 4.005
Its diluted EPS in the last 12-months stands at $0.93 per share while it has a forward price to earnings multiple of 40.3226 and a PEG multiple of 4.005. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into LeMaitre Vascular Inc’s profitability.
LeMaitre Vascular Inc stock is trading at a EV to sales ratio of 6.1959 and a EV to EBITDA ratio of 26.0167. Its price to sales ratio in the trailing 12-months stood at 6.2693.
LeMaitre Vascular Inc stock pays annual dividends of $0.515 per share, indicating a yield of 0.87% and a payout ratio of 56.99%.
Balance sheet and cash flow metrics
- Total Assets
- $314.87 million
- Total Liabilities
- $23.90 million
- Operating Cash Flow
- $-2964000.00
- Capital Expenditure
- $2.13 million
- Dividend Payout Ratio
- 56.99%
LeMaitre Vascular Inc ended 2023 with $314.87 million in total assets and $0 in total liabilities. Its intangible assets were valued at $314.87 million while shareholder equity stood at $274.17 million.
LeMaitre Vascular Inc ended 2023 with $71000.00 in deferred long-term liabilities, $23.90 million in other current liabilities, 238000.00 in common stock, $100.71 million in retained earnings and $65.95 million in goodwill. Its cash balance stood at $16.68 million and cash and short-term investments were $81.01 million. The company’s total short-term debt was $2,057,000 while long-term debt stood at $0.
LeMaitre Vascular Inc’s total current assets stands at $164.77 million while long-term investments were $0 and short-term investments were $64.33 million. Its net receivables were $25.37 million compared to accounts payable of $3.37 million and inventory worth $53.78 million.
In 2023, LeMaitre Vascular Inc's operating cash flow was $-2964000.00 while its capital expenditure stood at $2.13 million.
Comparatively, LeMaitre Vascular Inc paid $0.57 in dividends in 2023.
Other key metrics
- Current Trading Price
- $64.91
- 52-Week High
- $67.9118
- 52-Week Low
- $40.4063
- Analyst Target Price
- $62.33
LeMaitre Vascular Inc stock is currently trading at $64.91 per share. It touched a 52-week high of $67.9118 and a 52-week low of $67.9118. Analysts tracking the stock have a 12-month average target price of $62.33.
Its 50-day moving average was $57.37 and 200-day moving average was $50.18 The short ratio stood at 4.06 indicating a short percent outstanding of 0%.
Around 1179.8% of the company’s stock are held by insiders while 8766.5% are held by institutions.
Frequently Asked Questions About LeMaitre Vascular Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access in patients with or without a previously-failed synthetic graft; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient’s body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.